Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tjeerd J Postma

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Anticancer Research|August 28, 2004
Serum levels of S-100B protein and neuron-specific enolase in glioma patients: a pilot studyMaaike J Vos, Tjeerd J Postma, Frans Martens, et al.
Neuro-Oncology Practice|August 7, 2019
Epilepsy in the end of life phase of brain tumor patients: a systematic reviewJohan A F Koekkoek, Linda Dirven, Jaap C Reijneveld, et al.
BMJ Supportive & Palliative Care|March 20, 2014
Seizures in patients with high-grade glioma: a serious challenge in the end-of-life phaseEefje M Sizoo, Johan A F Koekkoek, Tjeerd J Postma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2003
Thallium-201 single-photon emission computed tomography as an early predictor of outcome in recurrent gliomaMaaike J Vos, Otto S Hoekstra, Frederik Barkhof, et al.
Plos One|June 26, 2014
Patients' preferences for participation in treatment decision-making at the end of life: qualitative interviews with advanced cancer patientsLinda Brom, H Roeline W Pasman, Guy A M Widdershoven, et al.
Neuro-Oncology Practice|June 3, 2015
The association between cognitive functioning and health-related quality of life in low-grade glioma patientsFlorien W Boele, Maaike Zant, Emma C E Heine, et al.
CNS Oncology|October 7, 2017
Visual inspection of MR relative cerebral blood volume maps has limited value for distinguishing progression from pseudoprogression in glioblastoma multiforme patientsMelissa Kerkhof, Pauline L Tans, Rogier E Hagenbeek, et al.
Heliyon|February 17, 2023
Frequency and burden of potentially treatable symptoms in glioma patients with stable diseaseJantine G Röttgering, Vera Belgers, Mathilde C M Kouwenhoven, et al.
Neuroradiology|July 15, 2011
MRI and thallium-201 SPECT in the prediction of survival in gliomaMaaike J Vos, Johannes Berkhof, Otto S Hoekstra, et al.
Neurology|April 29, 2025
Long-Term Follow-Up Results of Antiseizure Medication Withdrawal in Grade 2 and 3 Glioma Patients: A Prospective Observational StudyPim B van der Meer, Melissa Kerkhof, Linda Dirven, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Anticancer Research|August 28, 2004
Serum levels of S-100B protein and neuron-specific enolase in glioma patients: a pilot studyMaaike J Vos, Tjeerd J Postma, Frans Martens, et al.
Neuro-Oncology Practice|August 7, 2019
Epilepsy in the end of life phase of brain tumor patients: a systematic reviewJohan A F Koekkoek, Linda Dirven, Jaap C Reijneveld, et al.
BMJ Supportive & Palliative Care|March 20, 2014
Seizures in patients with high-grade glioma: a serious challenge in the end-of-life phaseEefje M Sizoo, Johan A F Koekkoek, Tjeerd J Postma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2003
Thallium-201 single-photon emission computed tomography as an early predictor of outcome in recurrent gliomaMaaike J Vos, Otto S Hoekstra, Frederik Barkhof, et al.
Plos One|June 26, 2014
Patients' preferences for participation in treatment decision-making at the end of life: qualitative interviews with advanced cancer patientsLinda Brom, H Roeline W Pasman, Guy A M Widdershoven, et al.
Neuro-Oncology Practice|June 3, 2015
The association between cognitive functioning and health-related quality of life in low-grade glioma patientsFlorien W Boele, Maaike Zant, Emma C E Heine, et al.
CNS Oncology|October 7, 2017
Visual inspection of MR relative cerebral blood volume maps has limited value for distinguishing progression from pseudoprogression in glioblastoma multiforme patientsMelissa Kerkhof, Pauline L Tans, Rogier E Hagenbeek, et al.
Heliyon|February 17, 2023
Frequency and burden of potentially treatable symptoms in glioma patients with stable diseaseJantine G Röttgering, Vera Belgers, Mathilde C M Kouwenhoven, et al.
Neuroradiology|July 15, 2011
MRI and thallium-201 SPECT in the prediction of survival in gliomaMaaike J Vos, Johannes Berkhof, Otto S Hoekstra, et al.
Neurology|April 29, 2025
Long-Term Follow-Up Results of Antiseizure Medication Withdrawal in Grade 2 and 3 Glioma Patients: A Prospective Observational StudyPim B van der Meer, Melissa Kerkhof, Linda Dirven, et al.
Pageof 5